Literature DB >> 27081770

Melioidosis: where do we stand in the development of an effective vaccine?

Laura A Muruato1, Alfredo G Torres1,2.   

Abstract

Entities:  

Keywords:  Burkholderia pseudomallei; antigens; immune protection; melioidosis; vaccine

Mesh：

Substances：

Year:  2016        PMID： 27081770     DOI： 10.2217/fmb-2015-0018

Source DB:  PubMed          Journal:  Future Microbiol        ISSN： 1746-0913            Impact factor:   3.165


× No keyword cloud information.
  4 in total

Review 1.  Combating the great mimicker: latest progress in the development of Burkholderia pseudomallei vaccines.

Authors:  Nittaya Khakhum; Itziar Chapartegui-González; Alfredo G Torres
Journal:  Expert Rev Vaccines       Date:  2020-07-15       Impact factor: 5.217

2.  Boosting of post-exposure human T-cell and B-cell recall responses in vivo by Burkholderia pseudomallei-related proteins.

Authors:  Arnone Nithichanon; Louise J Gourlay; Gregory J Bancroft; Manabu Ato; Yoshimasa Takahashi; Ganjana Lertmemongkolchai
Journal:  Immunology       Date:  2017-02-09       Impact factor: 7.397

Review 3.  Melioidosis.

Authors:  W Joost Wiersinga; Harjeet S Virk; Alfredo G Torres; Bart J Currie; Sharon J Peacock; David A B Dance; Direk Limmathurotsakul
Journal:  Nat Rev Dis Primers       Date:  2018-02-01       Impact factor: 52.329

4.  Melioidosis: The hazards of incomplete peer-review.

Authors:  Direk Limmathurotsakul; Frances Daily; Sotharith Bory; Gaetan Khim; W Joost Wiersinga; Alfredo G Torres; David A B Dance; Bart J Currie
Journal:  PLoS Negl Trop Dis       Date:  2019-03-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.